Kahalalides V-Y isolated from a Hawaiian collection of the sacoglossan mollusk Elysia rufescens

Journal of Natural Products

Volumn 71, Issue 5, 2008, Pages 772-778

  Rao, Karumanchi V ^a,c   Na, MinKyun ^a,c   Cook, Jennifer C ^a,c   Peng, Jiangnan ^a,c   Matsumoto, Rae ^b,c   Hamann, Mark T ^a,c  

^a National Center for the Development of Natural Products

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c Department of Pharmacognosy ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DEPSIPEPTIDE; HYDROXYPROLINE; KAHALALIDE D; KAHALALIDE V; KAHALALIDE W; KAHALALIDE X; KAHALALIDE Y; PROLINE;

ARTICLE; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; ELYSIA RUFESCENS; MOLLUSC; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ANALYSIS;

ANIMALS; DEPSIPEPTIDES; HAWAII; MARINE BIOLOGY; MOLECULAR STRUCTURE; MOLLUSCA;

ALGAE; BRYOPSIS; ELYSIA RUFESCENS;

EID: 45249085953     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np070508g     Document Type: Article

References (19)

1. Becerro, M. A.; Goetz, G.; Paul, V. J.; Scheuer, P. J. J Chem. Ecol. 2001, 27, 2287-2899.
2. Ireland, C.; Scheuer, P. J. Science 1979, 205, 9229-23.
3. Hamann, M. T.: Scheuer, P. J. J. Am. Chem. Soc. 1993, 115, 5825-5826.
4. Hamann, M. T.; Otto. C. S.; Scheuer. P. J.: Dunbar, D. C. J. Org. Chem. 1996, 61, 6594-6600.
5. Yukiko, K.; Tsuyoshi. F.; Bryan, S.; Yoshitsugi, H.; Hiroshi. N. J. Nat. Prod. 1999, 62, 1169-1172.
6. Horgen, F. D.; de los Santos, D. B.; Goetz, G.; Sakamoto, B.; Kan, Y.; Nagai, H.; Scheuer. P. J. J. Nat. Prod. 2000, 63, 152-154.
7. Andrey, D.; Takashi, I.; Terumi, N.; Bryan, S.; Michio, N.; Hiroshi, N. Tetrahedron 2006. 62, 1301-1308.
8. Tilyi, S.; Naik, C. G. J. Mass Spectrom. 2007, 42, 70-80.
9. Goetz, G.; Nakao, Y.; Scheuer, P. J. J Nat. Prod. 1997, 60, 562-567.
10. Hamann, M. T. Invest. Drugs Database Drug Rep. 2004, 657.
11. "Phase II Trials Study Kahalalide F in Lung Cancer and Melanoma" obtained September 2004 from Cancer Compass.
12. "Kahalalide F Enters Phase II Liver Carcinoma Trials". PharmaMar, Inc. Press release obtained March 2003.
13. Garcfa-Rocha, M.; Bonay, P.; Avila, J. Cancer Lett. 1996, 99, 43-50.
14. Suárez, Y.; González, L.; Cuadrado, A.; Berciano, M.; Lafarga, M.; Muñoz, A. Mol. Cancer Ther. 2003, 2, 863.
15. Sewell, J. M.; Mayer, I.; Langdon, S. P.; Smyth, J. F.; Jodrell, D. I.; Guichard, S. M. Eur. J. Cancer 2005 41, 1637-1644.
16. Janmaat, M. L.; Rodriguez, J. A.; Jimeno, J.; Kruyt, F. A. E.; Giaccone, G. Mol. Pharmacol. 2005, 68, 502-510.
17. Shilabin, A. G.; Kasanah, N.; Wedge, D. E.; Hamann, M. T. J. Med. Chem. 2007, 50, 4340-4350.
18. Marfey, P. Carlsberg Res. Commun. 1984, 49, 591-596.
19. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092-4096.